Skip to content

Clinical trials

Myeloproliferative Disorders trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Denmark Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20131
20141
20153
20181
20202
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting4
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation4
Fred Hutchinson Cancer Center2
Novartis Pharmaceuticals2
Geron Corporation1
Inge Marie Svane1
Karyopharm Therapeutics Inc1
Odense University Hospital1
Sierra Oncology LLC - a GSK company1
Takeda1
Terumo BCT1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders15
Primary Myelofibrosis7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Bone Marrow Diseases3
Hematologic Diseases3
Multiple Myeloma3
Thrombocythemia, Essential3
Thrombocytosis3
Blast Crisis2
Hodgkin Disease2

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.